SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-057776
Filing Date
2020-05-07
Accepted
2020-05-07 08:11:17
Documents
13
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018889d1_8k.htm   iXBRL 8-K 26390
2 EXHIBIT 99.1 tm2018889d1_ex99-1.htm EX-99.1 74946
  Complete submission text file 0001104659-20-057776.txt   286179

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnta-20200507.xsd EX-101.SCH 3201
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnta-20200507_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnta-20200507_pre.xml EX-101.PRE 22720
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2018889d1_8k_htm.xml XML 3499
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

IRS No.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50797 | Film No.: 20854669
SIC: 2836 Biological Products, (No Diagnostic Substances)